Litcius/Paper detail

Buparlisib and Paclitaxel in Patients with Head and Neck Squamous Cell Carcinoma: Immunogenomic Biomarkers of Efficacy from the BERIL-1 Study

Antoine Desîlets, Justin Lucas, Lisa Licitra, Sunny Lu, Archie Tse, Tom Tang, Kevin Dreyer, Nanhai He, L. Birgerson, Sandrine Faivre, Denis Soulières

2025Targeted Oncology8 citationsDOI

Topics & Concepts

MedicinePaclitaxelHead and neckHead and neck squamous-cell carcinomaBasal cellInternal medicineOncologyCarcinomaHead and neck cancerChemotherapyRadiation therapySurgeryHead and Neck Cancer StudiesCancer Immunotherapy and BiomarkersNonmelanoma Skin Cancer Studies
Buparlisib and Paclitaxel in Patients with Head and Neck Squamous Cell Carcinoma: Immunogenomic Biomarkers of Efficacy from the BERIL-1 Study | Litcius